24/7 Patient Assistance: 760-405-8205

Eve Rodler, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Eve Rodler is board certified medical oncologist based in Sacramento, California. She did her medical schooling at the George Washington University School of Medicine and pursued her residency in Internal Medicine at the Harbor-UCLA Medical Center. She also did a fellowship in Hematology/Oncology at the University of California-Davis. Dr. Rodler has been practicing for about two decades and is presently available for consultation at the VA Northern California Health Care System and University of California, Davis Medical center. She has also contributed to several research publications.



  • Education & Training

    dept_icon

    George Washington University

    Medical School

    dept_icon

    Harbor - UCLA Medical Center

    Residency

    dept_icon

    University of California Davis

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    University Of California, Davis

    Languages: English/Spanish

    (916) 703-5398

    4860 Y St Ste 3100

    Sacramento, California 95817

    Read More

    VA Northern California Health Care System

    Languages: English/Spanish

    (925) 372-2000

    150 Muir Rd

    Martinez, California 94553

    Read More
  • Publications & Memberships

    Dr. Eve Rodler has contributed to 3 publications.

    Analysis of Clinical Prognostic Factors for Adult Patients with Head and Neck Sarcomas.

    Chang, A. E.,Chai, X.,Pollack, S. M.,Loggers, E.,Rodler, E.,Dillon, J.,Parvathaneni, U.,Moe, K. S.,Futran, N.,Jones, R. L.; Otolaryngol Head Neck Surg. 2014 Sep 27.

    See more >>

    A Contemporary Large Single-Institution Evaluation of Resected Retroperitoneal Sarcoma.

    Bremjit, P. J.,Jones, R. L.,Chai, X.,Kane, G.,Rodler, E. T.,Loggers, E. T.,Pollack, S. M.,Pillarisetty, V. G.,Mann, G. N.; Ann. Surg. Oncol.. 2014 Mar 13.

    See more >>

    Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates.

    Meyer, J. M.,Perlewitz, K. S.,Hayden, J. B.,Doung, Y. C.,Hung, A. Y.,Vetto, J. T.,Pommier, R. F.,Mansoor, A.,Beckett, B. R.,Tudorica, A.,Mori, M.,Holtorf, M. L.,Afzal,...; Clin. Cancer Res.. 2013 Oct 18.

    See more >>

    Memberships

    American Society of Clinical Oncology

    Southwestern Oncology Group